TG Therapeutics, Inc.

TG Therapeutics, Inc.

TGTX
TG Therapeutics, Inc.US flagNASDAQ Capital Market
53.95
USD
-0.01
- -
8.26BMarket Cap

TG Therapeutics, Inc. (TGTX) Stock Split History

Learn about TG Therapeutics, Inc.'s most recent 4-for-225 basis stock split on April 30, 2012. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about TG Therapeutics, Inc.'s most recent stock split

Split Date: 2012-04-30
Split Ratio: 4:225
Price Before Split: $0.11
Price After Split: $0.00

Developer API

Get TGTX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/TGTX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 56.25 times fewer shares (a 4:225 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of TG Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2012-04-304:225Yes$0.11$0.00
2011-07-141:50Yes$0.01$0.00
2003-09-291:5YesN/AN/A

About TG Therapeutics, Inc.

Company overview and industry information

TG Therapeutics, Inc. (TGTX) operates in the Biotechnology industry. The recent 4-for-225 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to TG Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.